Acne - Pipeline Assessment and Market Forecasts to 2017

Introduction

GlobalData, the industry analysis specialist, has released a new report, “Acne - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global acne therapeutics market. The report identifies the key trends shaping and driving the global acne therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the existing market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global acne therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData’s research suggests that the global acne therapeutics market was worth $2.9 billion in 2009. It is estimated to reach revenues of $3.1 billion by 2017 at a Compound Annual Growth Rate (CAGR) of 0.7%. The moderate increase in revenues is attributed to the overcrowding of the market with generics and the increased acceptance of alternative therapies such as photodynamic therapy and Ultraviolet (UV)/blue light therapy. The current market has several products which treat acne by targeting different etiologic factors involved in the development of acne. Solodyn (minocycline hydrochloride) currently dominates the acne therapeutics market, followed by Doryx (doxycycline). The acne therapeutics market is witnessing a shift towards combination products, using two or more effective acne treatments. The currently marketed combination products such as Duac and Ziana are projected to steadily increase their revenues.

Scope

The report provides information on the key drivers and challenges in the acne market. Its scope includes:
- Annualized global acne therapeutics market revenues data from 2001 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. These drugs act by targeting bacterial protein synthesis, modifying keratinization patterns, exhibiting anti-inflammatory properties and selectively binding to retinoic acid receptors and inhibiting enzymes important for the bacteria.
- Analysis of the current and future market competition in the global acne therapeutics market. The key market players covered are Medicis, Mayne Pharma, Galderma Laboratories, Stiefel Laboratories and Allergan.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the acne therapeutics market

Highlights

Reasons to buy

The report will enhance your decision making capability. It will allow you to:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipelines.
- Develop business strategies by understanding the trends shaping and driving the global acne therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global acne therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global acne therapeutics market landscape? – Identify, understand and capitalize.

Report Highlights
Cosmo Pharmaceuticals
Stiefel, a GSK company
Galderma S.A.
Allergan Inc (Allergan)
Medicis Pharmaceutical Corporation
[Cerrar las informaciones del articulo de mercado]

TABLE OF CONTENTS

1 Table of contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Acne Therapeutics Market: Market Characterization 5
2.1 Disease Overview 5
2.2 Clinical Symptoms and Diagnosis 5
2.3 Treatment 6
2.3.1 Treatment Options for Acne 6
2.4 Prevention 6
2.5 Acne Therapeutics Market Overview 7
2.6 Acne Therapeutics Market Size 7
2.7 Acne Therapeutics Market, Forecast and CAGR 9
2.8 Drivers and Barriers for the Acne Therapeutics Market 10
2.8.1 Drivers for the Acne Therapeutics Market 10
2.8.2 Barriers for the Acne Therapeutics Market 10
2.9 Opportunity and Unmet Need 11
2.10 Key Takeaway 12
3 Acne Therapeutics Market: Competitive Assessment 13
3.1 Overview 13
3.2 Strategic Competitor Assessment 13
3.3 Product Profile for the Major Marketed Products in the Acne Therapeutics Market 14
3.3.1 Solodyn (Minocycline hydrochloride) 14
3.3.2 Doryx ((Doxycyclin hyclate) Vibra-Tabs, Vibramycin) 15
3.3.3 Epiduo (Benzoyl peroxide 2.5% and Adapalene 0.1%) 16
3.3.4 Duac (clindamycin phosphate 1% and benzoyl peroxide 5%) 18
3.3.5 Tazorac (Tazarotene, Avage) 19
3.3.6 Ziana (Clindamycin phosphate 1.2% and Tretinoin 0.025%) 20
3.3.7 Differin (Adapalene) 21
3.4 Key Takeaway 23
4 Acne Therapeutics Market: Pipeline Assessment 24
4.1 Overview 24
4.2 Strategic Pipeline Assessment 24
4.2.1 Technology Trends Analytic Framework 24
4.3 Acne Therapeutics – Promising Drugs under Clinical Development 26
4.4 Molecule Profile for Promising Drugs under Clinical Development 26
4.4.1 CB-03-01 (cortexolone 17a-proprionate) 26
4.4.2 Dapsone Gel 5% in combination with adapalene gel 0.1% / benzoyl peroxide 4% gel 27
4.4.3 Veltin 28
4.5 Acne Therapeutics Market – Clinical Pipeline by Mechanism of Action 29
4.6 Acne – Pipeline by Clinical Phase of Development 30
4.6.1 Acne Therapeutics – Phase III Clinical Pipeline 31
4.6.2 Acne Therapeutics – Phase II Clinical Pipeline 31
4.6.3 Acne Therapeutics – Phase I Pipeline 32
4.6.4 Acne Therapeutics – Preclinical Pipeline 33
4.6.5 Acne Therapeutics – Discovery Pipeline 33
4.7 Discontinued Drugs for Acne 34
4.8 Key Takeaway 34
5 Acne Therapeutics Market: Implications for Future Market Competition 35
6 Acne Disease Market: Future Players in the Acne therapeutics market 37
6.1 Introduction 37
6.2 Cosmo Pharmaceuticals 37
6.2.1 Company Overview 37
6.2.2 Acne Disease Portfolio 38
6.2.3 Acne Product Portfolio 38
6.3 Stiefel, a GSK company 39
6.3.1 Company Overview 39
6.3.2 Acne Portfolio 40
6.3.3 Acne Product Portfolio 40
6.4 Galderma S.A. 40
6.4.1 Company Overview 40
6.4.2 Acne Portfolio 41
6.5 Allergan Inc (Allergan) 41
6.5.1 Company Overview 41
6.5.2 Acne Portfolio 43
6.5.3 Acne Product Portfolio 43
6.6 Medicis Pharmaceutical Corporation 44
6.6.1 Company Overview 44
6.6.2 Acne Portfolio 45
6.6.3 Solodyn (Minocycline hydrochloride) 45
6.6.4 Ziana (Clindamycin phosphate 1.2% and Tretinoin 0.025%) 46
7 Acne Therapeutics Market: Appendix 49
7.1 Market Definitions 49
7.2 Scope of Pipeline Research 49
7.3 Research Methodology 50
7.3.1 Coverage 50
7.3.2 Secondary Research 51
7.3.3 Forecasting 51
7.3.4 Primary Research 54
7.3.5 Expert Panels 54
7.4 Contact Us 54
7.5 Disclaimer 54
7.6 Sources 55
[Cerrar la tabla de contenidos]

LIST OF TABLES

1.1 List of Tables
Table 1: Acne Therapeutics Market, Global, Revenues ($bn), 2001-2009 8
Table 2: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2009-2017 9
Table 3: Acne Therapeutics – Most Promising Drugs Under Clinical Development, 2010 26
Table 4: Acne Therapeutics – Phase III Clinical Pipeline, 2010 31
Table 5: Acne Therapeutics – Phase II Clinical Pipeline, 2010 31
Table 6: Acne Therapeutics – Phase I Pipeline, 2010 32
Table 7: Acne Therapeutics – Preclinical Pipeline, 2010 33
Table 8: Acne – Discovery Pipeline, 2010 33
Table 9: List of Discontinued Drugs for Acne, 2010 34
Table 10: Cosmo Pharmaceuticals – Pipeline Products, 2010 38
Table 11: Stiefel, a GSK company – Pipeline Products, 2010 40
Table 12: Galderma – Acne Pipeline Products, 2010 41
Table 13: Allergan Inc – Acne Pipeline Products, 2010 43
Table 14: Medicis Pharmaceutical Corporation – Acne therapeutics marketed Products, 2010 45
LIST OF FIGURES

1.2 List of Figures
Figure 1: Acne Therapeutics Market, Global, Revenues ($bn), 2001-2009 8
Figure 2: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2009-2017 9
Figure 3: Opportunity and Unmet Need in the Acne Therapeutics Market, 2010 12
Figure 4: Strategic Competitor Assessment of the Major Marketed Products for Acne, 2010 14
Figure 5: Technology Trends Analytic Framework of the Acne Pipeline, 2010 25
Figure 6: Technology Trends Analytic Framework of the Acne Pipeline - Description, 2010 25
Figure 7: Acne – Clinical Pipeline by Mechanism of Action, 2010 29
Figure 8: Acne Pipeline by Phase of Clinical Development, 2010 30
Figure 9: Implications for Future Market Competition in the Acne Therapeutics Market, 2010 35
Figure 10: Acne Therapeutics Market – Clinical Pipeline by Company, 2010 37
Figure 11: GlobalData Methodology, 2010 50
Figure 12: GlobalData Market Forecasting Model, 2010 53
[Ocultar lista de tablas / figuras]